Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome
Both achieve approximately 20% weight reduction, making them the most effective anti-obesity pharmacotherapies
The design and control of Phase 3 studies is complex and challenging
Other routinely prescribed drugs, vitamins, and enteral or parenteral nutrition products have not demonstrated significant pharmacokinetic or pharmacodynamic interference
Recently, peptides that target next-generation immune checkpoints, such as T-cell immunoglobulin-3 (TIM-3), lymphocyte activation gene 3 (LAG-3), and T-cell immunoreceptor with Ig and ITIM domains (TIGIT), have attracted increasing attention
You assume full responsibility for safe handling and use in accordance with all applicable regulations.